Acute Myelogenous Leukemia

Showing NaN - NaN of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • XmAb14045
    • Jacksonville, Florida
    • +8 more
    Mar 4, 2022

    Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Gilbert, Arizona
    • +23 more
    Feb 22, 2022

    Cancer, Acute Lymphoblastic Leukemia, Lymphoma Trial in Seattle (Promoting Resilience In Stress Management (PRISM))

    Completed
    • Cancer
    • +6 more
    • Promoting Resilience In Stress Management (PRISM)
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 28, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Acute Myelogenous Leukemia Trial in United States (KIR genotype)

    Completed
    • Acute Myelogenous Leukemia
    • KIR genotype
    • Scottsdale, Arizona
    • +18 more
    Mar 9, 2021

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,

    Completed
    • Acute Myeloid Leukemia
    • Acute Myelogenous Leukemia
    • Standard dose cytarabine for induction
    • +3 more
    • Birmingham, Alabama
    • +12 more
    May 8, 2018

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (IGN523)

    Completed
    • Acute Myelogenous Leukemia
    • Acute Myeloid Leukemia
    • La Jolla, California
    • +5 more
    Feb 22, 2016

    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • BMS-936564 (Anti-CXCR4)
    • Birmingham, Alabama
    • +10 more
    Mar 5, 2015

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)

    Completed
    • Acute Myelogenous Leukemia
    • Acute Myeloid Leukemia
    • Phoenix, Arizona
    • +19 more
    Mar 17, 2014

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,

    Completed
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Birmingham, Alabama
    • +12 more
    Mar 17, 2014

    Acute Myelogenous Leukemia Trial in United States (clofarabine (IV formulation))

    Completed
    • Acute Myelogenous Leukemia
    • clofarabine (IV formulation)
    • Los Angeles, California
    • +11 more
    Mar 17, 2014

    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

    Completed
    • Acute Lymphoblastic Leukemia
    • +5 more
    • VCL-CB01
    • Phosphate-buffered Saline (PBS)
    • Tucson, Arizona
    • +21 more
    Jul 31, 2013

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia Trial in Houston, Seattle (PR104)

    Unknown status
    • Acute Myelogenous Leukemia
    • Acute Lymphocytic Leukemia
    • Houston, Texas
    • +1 more
    Aug 30, 2012